FGD© (Future Generics Database)© presents:


NexGenerix©

The Generic Drugs Selection Tool

Download Atazanavir the monograph sample of NexGenerix©

What: Patent and market research database for generic drug selection

When: 77 NCEs due for generic launch between years 2016 to 2025

Where: Covers 37 countries including US, EU and Japan

Why: Best-in-class value, up-to-date, comprehensive and affordable

Who: Business decision makers in the pharmaceutical industry

NexGenerix© highlights:

Patents:

Patent Expiry Extension (34 countries):

Patent Term Extension/US

Special Protection Certificate/signatories countries

Patent extension/other national markets

Patent Expiry (34 countries)

NCE patent priority and filing dates

Expiry Dates

Ownership, Developer/Licensee

Indication

Direct access to patent claims, synopsis, citations and full text

Markets:

First market authorization date (34 countries)

Market term extension (34 countries)

Orphan drug exclusivity (ODE) (34 countries)

Pediatric drugs exclusivity (PDE) (34 countries)

Other Information:

Paragraph IV patent challenge (US)

Dosage forms (US, Japan, UK and France)

Drug substance COS/DMF (34 countries)

Indication

Global sales by product

Information Filters:

by fields, key words, text and numerical values e.g.

E.g. country, date, indication, active ingredient, dosage form